Open access
Aug 2026
Identifying candidate therapeutic targets in amyotrophic lateral sclerosis through a transcriptome-wide machine-learning consensus approach for drug repurposing.
The results provide transparent, hypothesis-generating gene, pathway, and compound priorities, but they do not establish biomarkers, therapeutic efficacy, or clinical suitability and require validation in independent cohorts and experimental ALS models.
Enrique J. de Andrés-Galiana, J. Fernández-Martínez, G. Morís
· Neuroscience · 0 citations